Question 1

What is Leo Pharma (Denmark) known for?

Accepted Answer

In research, Leo Pharma (Denmark) stands highest in Health Sciences (#5,695 of 16,688 worldwide), Life Sciences (#4,175 of 11,023 worldwide) and Medicine (#5,720 of 14,558 worldwide), over all time.

Question 2

How does Leo Pharma (Denmark) rank in research?

Accepted Answer

Leo Pharma (Denmark) ranks #12,373 of 34,923 institutions worldwide on research quality over all time, and #78 of 179 in Denmark.

Question 3

Who are the top researchers at Leo Pharma (Denmark)?

Accepted Answer

Ranked on the quality score, David Adrian Ewald, Paola Lovato and Jakob Felding lead among researchers whose main affiliation is Leo Pharma (Denmark).

Question 4

What are the most cited papers from Leo Pharma (Denmark)?

Accepted Answer

The most cited paper from Leo Pharma (Denmark) is "The role of lipid components in lipid nanoparticles for vaccines and gene therapy" (Camilla Hald Albertsen, Jayesh A. Kulkarni, Dominik Witzigmann et al., 2022), with 1,183 citations. Next come "Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*" (627) and "Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer" (615).

Question 5

Which research topics does Leo Pharma (Denmark) publish most on?

Accepted Answer

By volume in 2022-now: Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Contact Dermatitis and Allergies and Asthma and respiratory diseases.

Question 6

Which keywords describe research at Leo Pharma (Denmark)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Immune Dysregulation, Filaggrin, Skin Microbiome, Epidemiology, Regulatory T Cells, Immune System, TGF-ß and Inflammatory Cytokines.

Question 7

Which fields of science does Leo Pharma (Denmark) work in?

Accepted Answer

In 2022-now, 52% of research at Leo Pharma (Denmark) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (50%), Immunology and Microbiology (20%), Biochemistry, Genetics and Molecular Biology (8%). It does 2.1× the world's share of Life Sciences.

Question 8

Is Leo Pharma (Denmark)'s research output growing?

Accepted Answer

Output in 2022-2025 was 33% lower than in 2018-2021.